BLINKLAB LIMITED - News & Media

1.11%

44.5¢

Market Cap $38.83M

Technology Software - Application

BlinkLab Limited (ASX: BB1) is a trailblazer in digital healthcare, leveraging AI and... BlinkLab Limited (ASX: BB1) is a trailblazer in digital healthcare, leveraging AI and machine learning in mobile applications to revolutionise neurodevelopmental condition diagnosis like ASD and ADHD. Born from extensive research at Princeton University, BlinkLab offers early detection and effective intervention solutions through its smartphone-based diagnostic platform. The company is committed to improving mental health care globally, starting with the youngest patients.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Articles & Videos

BlinkLab teams up with Monash to trial tech in autism, ADHD study

BlinkLab (ASX:BB1) has confirimed its involvement in a Monash Uni-based study examining its tech's ability to diagnose autism and ADHD.

13 Nov 2024 10:07 (AEDT)

BlinkLab teams up with Bates College in Maine, USA to re-jig software for FND diagnosis

BlinkLab has teamed up with a college in Maine to assess its tech in the field of functional neurological disorder (FND) diagnosis.

06 Jun 2024 14:01 (AEST)

BlinkLab jumps as Dutch dementia study kicks off

BlinkLab (ASX:BB1) jumped close to 4% in morning trades on Wednesday as the company sets up for a dementia trial in the Netherlands.

05 Jun 2024 11:17 (AEST)

BlinkLab partnership with US smart-tech Turning Pointe raises hopes for autism kids

BlinkLab partners with US-based Turning Pointe Autism Foundation for clinical study ahead of its FDA registration study later in the year

02 May 2024 11:19 (AEST)

Why Princeton Professor rates BlinkLab's autism & ADHD screening app

In this interview with Sonia Madigan, Professor Sam Wang of Princeton University discusses the development and potential of BlinkLab's (ASX:BB1) AI-driven smartphone app, designed to screen for autism and ADHD.

30 Apr 2024 15:11 (AEST)

BlinkLab up as much as 50% on debut

BlinkLab (ASX:BB1) has traded up as much as 50 per cent on listing on the ASX this morning, breaking the ASX IPO drought.

04 Apr 2024 14:09 (AEDT)

Brian Leedman’s BlinkLab to join ASX: AI-driven smartphone app screens for autism, ADHD

BlinkLab is a world-first, AI-driven digital healthcare venture, that uses a smartphone and facial recognition to detect autism and ADHD. It’s listing on the ASX next Thursday (April 4) under the code BB1. BlinkLab’s development is being led by chair Brian Leedman - a founder of ResApp Health - the cough analysis app sold to Pfizer two years ago in a $179 million deal.

28 Mar 2024 08:54 (AEDT)

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 44.5¢		Change -0.005(1.11%)		Mkt cap ! $38.83M

Open	High	Low	Value	Volume
44.5¢	44.5¢	43.0¢	$54.26K	123.8K

Buyers (Bids)

No.	Vol.	Price($)
3	36706	43.5¢

Sellers (Offers)

Price($)	Vol.	No.
44.5¢	15000	2

View Market Depth

No.	Vol.	Price($)
2	24151	0.435
2	32600	0.430
1	2600	0.420
1	24390	0.410
1	100000	0.405

Price($)	Vol.	No.
0.445	15000	2
0.450	11666	1
0.475	4265	1
0.490	12368	1
0.500	20000	1

Last trade - 15.46pm 30/07/2025 (20 minute delay)


Last 44.0¢		Change -0.005 ( 2.22 %)
Open	High	Low	Volume
43.5¢	45.0¢	43.5¢	13614
Last updated 15.59pm 30/07/2025 ?

BB1 (ASX) Chart